Robert L. Rosiello
CIK 1645041 · EVP, Corp Dev & Strategy · last filed 2026-06-05
Robert L. Rosiello is an EVP, Corp Dev & Strategy who has filed 16 SEC Form 4 insider transactions across 5 companies since 2022. The most recent filing, for SANA, was dated Jun 5, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
16
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANA | Director | — | $2.68 | — | $0 | 2 | 2026-06-05 |
| MCRB | Director | — | $5.70 | — | $0 | 1 | 2025-08-06 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Director | — | $0.14 | — | $0 | 1 | 2024-10-04 |
| EVLO | Director | — | $0.00 | — | $0 | 2 | 2023-06-12 |
| Axcella Health Inc. (AXLA) Delisted | Director | — | $0.40 | — | $0 | 1 | 2022-11-18 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | SANA | Grant (A) | — | $0 | EDGAR |
| 2025-08-06 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | SANA | Grant (A) | — | $0 | EDGAR |
| 2024-10-04 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2023-04-18 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2022-11-18 | Axcella Health Inc. (AXLA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-07 | — | Tax (F) | −14,687 | -$264.4K | |
| 2016-11-08 | — | Tax (F) | −817 | -$18.0K | |
| 2016-08-05 | — | Tax (F) | −1,338 | -$31.5K |